Body Mass Index and Doses at Organs at Risk in a Mediterranean Population Treated with Postoperative Vaginal Cuff Brachytherapy
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose Association between body mass index (BMI) and doses in organs at risk during postoperative vaginal cuff brachytherapy (VCB) treatment has not been evaluated. The aim of this study was to analyse the impact of BMI on the dose delivered to bladder and rectum during high-dose-rate VCB using computed tomography (CT) scans at every fraction. Materials and Methods A retrospective analysis of 220 planning CT sets derived from 59 patients was conducted. Every planning CT was re-segmented and re-planned under the same parameters. Rectum and bladder dose-volume histogram values (D0.1cc, D1cc, and D2cc) were extracted and evaluated. The mean values for all applications per patient were calculated and correlated with BMI, as well as other factors influencing rectal and bladder doses. Multiple regression analysis performed to model organ at risk dose-volume parameters. Results According to World Health Organization (WHO), 6.8% of patients were normal, 35.6% were overweight, and 57.6% were class I obese. Median rectal doses were 133.5%, 110.9%, and 99.3% for D0.1cc, D1cc, and D2cc, respectively. The corresponding median bladder doses were 96.2%, 80.6%, and 73.3%, respectively. BMI did not show significant association with rectal doses. However, BMI did show a significant association with evaluated bladder dose metrics (D0.1cc, r=–0.366, p=0.004; D1cc, r=–0.454, p < 0.001; D2cc, r=–0.451, p < 0.001). BMI was retained in the multivariate regression models (D0.1cc, p=0.004; D1cc, p < 0.001; D2cc, p=0.001). Conclusion In this group of Mediterranean, overweight, and moderately obese patients, BMI showed association with lower bladder dose values, but not with rectal doses.
Abstract
Purpose Association between body mass index (BMI) and doses in organs at risk during postoperative vaginal cuff brachytherapy (VCB) treatment has not been evaluated. The aim of this study was to analyse the impact of BMI on the dose delivered to bladder and rectum during high-dose-rate VCB using computed tomography (CT) scans at every fraction. Materials and Methods A retrospective analysis of 220 planning CT sets derived from 59 patients was conducted. Every planning CT was re-segmented and re-planned under the same parameters. Rectum and bladder dose-volume histogram values (D0.1cc, D1cc, and D2cc) were extracted and evaluated. The mean values for all applications per patient were calculated and correlated with BMI, as well as other factors influencing rectal and bladder doses. Multiple regression analysis performed to model organ at risk dose-volume parameters. Results According to World Health Organization (WHO), 6.8% of patients were normal, 35.6% were overweight, and 57.6% were class I obese. Median rectal doses were 133.5%, 110.9%, and 99.3% for D0.1cc, D1cc, and D2cc, respectively. The corresponding median bladder doses were 96.2%, 80.6%, and 73.3%, respectively. BMI did not show significant association with rectal doses. However, BMI did show a significant association with evaluated bladder dose metrics (D0.1cc, r=–0.366, p=0.004; D1cc, r=–0.454, p < 0.001; D2cc, r=–0.451, p < 0.001). BMI was retained in the multivariate regression models (D0.1cc, p=0.004; D1cc, p < 0.001; D2cc, p=0.001). Conclusion In this group of Mediterranean, overweight, and moderately obese patients, BMI showed association with lower bladder dose values, but not with rectal doses.
참고문헌 (22)
- Fader AN, "Endometrial cancer and obesity : epidemiology, biomarkers, prevention and survivorship", Gynecol Oncol, 114, pp.121~127 (2009)
- Arem H, "Prediagnosis body mass index, physical activity, and mortality in endometrial cancer patients", J Natl Cancer Inst, 105, pp.342~349 (2013)
- van Roermund JG, "Periprostatic fat correlates with tumour aggressiveness in prostate cancer patients", BJU Int, 107, pp.1775~1779 (2011)
- Patil N, "The effect of obesity on rectal dosimetry after permanent prostate brachytherapy", Brachytherapy, 8, pp.218~222 (2009)
- Boyle JM, "Body mass index, dose to organs at risk during vaginal brachytherapy, and the role of three-dimensional CT-based treatment plan-ning", Brachytherapy, 13, pp.332~336 (2014)
- Jia WP, "Prediction of abdominal visceral obesity from body mass index, waist circumference and waist-hip ratio in Chinese adults : receiver operating characteristic curves analysis", Biomed Environ Sci, 16, pp.206~211 (2003)
- Lear SA, "The use of BMI and waist circumference as surrogates of body fat differs by ethnicity", Obesity(Silver Spring), 15, pp.2817~2824 (2007)
- Rapp K, "Obesity and incidence of cancer : a large cohort study of over 145, 000 adults in Austria", Br J Cancer, 93, pp.1062~1067 (2005)
- Reeves KW, "Obesity in relation to endometrial cancer risk and disease characteristics in the Women's Health Initiative", Gynecol Oncol, 121, pp.376~382 (2011)
- Manson JE, "Body weight and mortality among women", N Engl J Med, 333, pp.677~685 (1995)
- Arem H, "Body mass index, physical activity, and survival after endometrial cancer diagnosis : results from the Women's Health Initiative", Gynecol Oncol, 128, pp.181~186 (2013)
- von Gruenigen VE, "Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma : a Gynecologic Oncology Group study", Cancer, 107, pp.2786~2791 (2006)
- Crosbie EJ, "Body mass index does not influence post-treatment survival in early stage endometrial cancer : results from the MRC ASTEC trial", Eur J Cancer, 48, pp.853~864 (2012)
- Arem H, "Obesity and endometrial cancer survival : a systematic review", Int J Obes(Lond), 37, pp.634~639 (2013)
- Nout RA, "Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk(PORTEC-2) : an open-label, non-inferiority, randomised trial", Lancet, 375, pp.816~823 (2010)
- Sabater S, "Dose accumulation during vaginal cuff brachytherapy based on rigid", deformable registration vs. single plan addition, 2014, pp.13, 343~351
- Sabater S, "Reduction of rectal doses by removal of gas in the rectum during vaginal cuff brachytherapy", Strahlenther Onkol, 189, pp.951~956 (2013)
- Hoskin PJ, "The influence of applicator angle on dosimetry in vaginal vault brachytherapy", Br J Radiol, 75, pp.234~237 (2002)
- Hung J, "Image-based 3D treatment planning for vaginal cylinder brachytherapy : dosimetric effects of bladder filling on organs at risk", Int J Radiat Oncol Biol Phys, 83, pp.980~985 (2012)
- Sabater S, "Effect of rectal distention on vaginal cuff brachytherapy", Radiother Oncol, 106, pp.s365~366 (2013)
- Calle EE, "Overweight, obesity and cancer : epidemiological evidence and proposed mechanisms", Nat Rev Cancer, 4, pp.579~591 (2004)
- Small W Jr, "American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy", Brachytherapy, 11, pp.58~67 (2012)